SCHEMBL13729809

SCHEMBL13729809

O=C(c1ccc(NS(=O)(=O)c2ccc3ccccc3n2)cc1Cl)N1CCN(CC2CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKLR P30613 4/20 0.47
PKM P14618 1/20 0.47
HTR6 P50406 1/20 0.41
GPR6 P46095 1/20 0.41
KCNH2 Q12809 3/20 0.40
CCR2 P41597 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
GRIN2B Q13224 1/20 0.39
KDM2B Q8NHM5 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
FAAH O00519 1/20 0.37
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10008764 0.80 PKLR (0.75) PKLRPKMMEN1KMT2A
SCHEMBL16049821 0.79 PKLR (0.69) PKLR
SCHEMBL12476933 0.78 PKLR (0.45) PKLRPKMHTR6MEN1KMT2A
SCHEMBL10009388 0.77 PKLR (0.71) PKLRPKMMEN1KMT2A
SCHEMBL10008927 0.75 PKLR (0.68) PKLRPKMMEN1KMT2A
SCHEMBL20750615 0.73 CCR2 (0.49) KCNH2CCR2TP53PIK3CAMTOR
SCHEMBL16049789 0.72 PKLR (0.70) PKLR
SCHEMBL10008244 0.72 PKLR (0.64) PKLRPKMMEN1KMT2A
SCHEMBL6690559 0.72 HTR6 (0.45) PKLRPKMHTR6MEN1KMT2A
SCHEMBL20036185 0.71 PKLR (0.44) PKLRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2704720-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY Agios Pharmaceuticals, Inc. (US) 2014-03-12 EP disclosed
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 WO disclosed